NOVO NORDISK INC.
PLAINSBORO, NJ

Novo Nordisk Inc., a global healthcare company renowned for its leadership in diabetes care, operates with a long-standing history that exceeds 90 years. With headquarters based in Denmark, the company employs approximately 42,100 people across 79 countries and markets its products to more than 170 nations. As of 1995, Novo Nordisk has been actively incorporated in Florida, holding a status as a Foreign Profit Corporation (FORP) with a filed number F95000002635. The company places significant emphasis on integrated reporting, which aligns with its Triple Bottom Line business principle encompassing financial, environmental, and social responsibility. Novo Nordisk has maintained this practice since 2004, aiming to provide stakeholders with a holistic overview of its performance and strategic initiatives through a single, inclusive document. Novo Nordisk remains committed to sustainability and ethical practices, notably in its support of the 3Rs—Reduce, Refine, and Replace—in animal research. It views the UN Sustainable Development Goals as crucial for maximizing positive impact, particularly on health (Goal 3) and responsible consumption and production (Goal 12). The company endeavors to convert all its global production sites to 100% renewable power by 2020. In recent efforts toward social responsibility, Novo Nordisk initiated 'Project Opportunity' in 2013, a unique employment program that facilitates job placements for people with autism spectrum disorder (ASD) within the Danish division of the company. The current officers include Curtis Oltmans as Attorney, Kristine A. Bethe as Director, and Doug Langa as President. The last event recorded by the company was on October 18, 2007, with its annual report filed on April 9, 2024, demonstrating continued accountability and transparency in corporate reporting. For further information about Novo Nordisk Inc.'s operations, initiatives, or to explore their contributions towards healthcare innovation, visitors can refer to the company's official website at novonordisk.com.

KEY FACTS ABOUT NOVO NORDISK INC.

Company name
NOVO NORDISK INC.
Status
Active
Filed Number
F95000002635
FEI Number
06-1061602
Date of Incorporation
May 28, 1995
Age - 31 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://novonordisk.com
Phones
(609) 786-8316
(267) 809-7552
(166) 410-2018

NOVO NORDISK INC. NEAR ME

Principal Address
800 Scudders Mill Road,
Plainsboro,
NJ,
08536,
US

See Also

Officers and Directors

The NOVO NORDISK INC. managed by the three persons from Plainsboro on following positions: Auth, Director, President

Curtis Oltmans

Position
Auth Active
From
Plainsboro, NJ, NJ

Kristine A Bethe

Position
Director Active
From
Plainsboro, NJ, NJ

Doug Langa

Position
President Active
From
Plainsboro, NJ, NJ





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

October 18, 2007
CANCEL ADM DISS/REV
September 14, 2007
REVOKED FOR ANNUAL REPORT
October 21, 2005
REINSTATEMENT
September 16, 2005
REVOKED FOR ANNUAL REPORT
December 21, 2004
NAME CHANGE AMENDMENT
December 6, 1999
REINSTATEMENT
September 24, 1999
REVOKED FOR ANNUAL REPORT
November 24, 1997
REINSTATEMENT
September 26, 1997
REVOKED FOR ANNUAL REPORT

Annual Reports

2025
March 26, 2025
2024
April 9, 2024